00000nam 2200000zi 4500 9.909298 CaOODSP 20221107181856 m o d f cr ||||||||||| 220322t20222022onc o f00| 0 eng d 9780660426587 CaOODSP eng rda CaOODSP n-cn--- H139-40/2022E-PDF POL-0004 : drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement policy. [Ottawa] : Health Canada = Santé Canada, 2022. ©2022 1 online resource (17 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: POL-0004 : Politique d'application de la loi pour les bonnes pratiques de fabrication (BPF) des médicaments et les licences d’établissement de produits pharmaceutiques (LEPP). Issued also in HTML format. Replaces: Good Manufacturing Practices (GMP) and Establishment Licensing Enforcement Directive, v3 (August 31, 2018). "April 1, 2022." Drug factories Canada. Canada. Health Canada, issuing body. POL-0004 : (CaOODSP)9.909299 PDF 1.36 MB https://publications.gc.ca/collections/collection_2022/sc-hc/H139-40-2022-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/drug-good-manufacturing-practices-establishment-licensing-enforcement-directive-0004.html 210747